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Background: Anomalous pulmonary venous connection (APVC) is a rare, life threatening 
congenital heart disease presenting early in life. It may be partial (PAPVC) or total (TAPVC).  
PAPVC mainly involve the right pulmonary arteries and is associated with sinus venosus 
atrial septal defect with a low morbidity and mortality. TAPVC is classified into 
supracardiac, intracardiac, infracardiac and mixed types. It carries a high morbidity and 
mortality. The aim of this study was to determine the morphological patterns and surgical 
outcome of APVC at CARE hospital, Hyderabad-India. 
Methods: This was a prospective study form January 2004 to December 2006. Study included 
all patients who underwent surgery for anomalous pulmonary venous connection and 
followed up to the time of discharge. 
Results: A total of 65 patients with APVC were studied where the results revealed 60% had 
TAPVC and 40% had PAPVC. Mean age of presentation was 21.6 months for TAPVC 
compared to 135.2 months for PAPVC. Among all patients with PAPVC 84.6 % had sinus 
venosus atrial septal defect.  Supra-cardiac and intra-cardiac anomalous were the commonest 
type of TAPVC representing 43.6% and 35.9% respectively. Among all patients with TAPVC 
51.35% were associated with ostium secundum atrial septal defect, 74.4% had moderate to 
severe pulmonary hypertension. Overall mortality was 9.25%. Mortality within TAPVC 
group was 15.4% and none from PAPVC.  
Conclusion: It was concluded that TAPVC present early in life and is associated with ostium 
secundum atrial septal defect, pulmonary hypertension, high morbidity and mortality. 
Accurate diagnosis and early correction improves the surgical outcome.  
 
Introduction 
 
Anomalous Pulmonary Venous Connection 
(APVC) is one of the rare congenital heart 
diseases whereby, some or all of the 
pulmonary veins drain to the site other than 
left atrium1,2,3. Partial anomalous pulmonary 
venous connection (PAPVC) commonly 
involves the right pulmonary veins in more 
than 80% with normal drainage to the left 
side. About 90% of PAPVC are associated 
with Sinus Venosus Atrial Septal Defects -
SVASD1,2,3.  
 
Total anomalous pulmonary venous 
connection (TAPVC) involves all four 
pulmonary veins which form a common 
pulmonary chamber and drain into different  
 
 
sites. It is classified according to the site of 
drainage as Supracardiac, intracardiac, 
infracardiac and mixed type as a combination 
of the mentioned types4,5. Definite diagnosis  
 
of APVC is made by Trans-Thoracic 
Echocardiography and Trans-Esophageal 
Echocardiography (TEE) and rarely, cardiac 
catheterization is used when associated with 
other cardiac anomalies or  patient with age 
above 40 years to exclude coronary artery 
disease6,7,8. Clinical presentation and 
pathophysiology for PAPVC is similar to that 
of atrial septal defect (ASD) and the surgical 
treatment is directed towards closure of ASD 
while re-routing pulmonary veins into the left 
atrium using a patch. Surgical treatment 
carries a low morbidity and 0.9 % mortality 
rate3. TAPVC patients present with 
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decompensated heart with desaturation and 
therefore, early presentation 9. Surgical 
treatment depends on the type of connection 
and this carries a high morbidity and 
mortality4,10,11. A prospective study was done 
to determine the morphological pattern and 
operative outcome of the APVC at CARE 
Hospital, Hyderabad- India. 
 
Patients and Methods 
 
A prospective study was done from January 
2004 to December 2006 including all patients 
who underwent cardiac surgery for 
anomalous pulmonary connection (drainage).  
Those patients whom their data could not be 
retrieved were excluded from the study. 
Operating theatre registry and medical record 
department were used to obtain the necessary 
details which included age, sex, type of 
anomaly and type of surgery done, number of 
veins and type of ASD involved in PAPVC, 
type of TAPVC and its associated anomalies, 
duration of mechanical ventilation. Also 
presence of pulmonary hypertension by 
echocardiography, pulmonary vein(s) 
obstruction and mortality were recorded. Pre-
operative and post-operative 
echocardiography was done for diagnosis and 
control respectively. All patients were 
followed up to the time of discharge for any 
immediate complication. 
  
Surgical technique 
 
All patients with partial anomalies had 
glutaraldehyde treated pericardial patch 
closure of the ASD while re-routing 
pulmonary vein(s) into left atrium. Left 
pulmonary vein draining into innominate vein 
was divided and anastomozed to the left atrial 
appendage. 
 
All patients with supra-cardiac and infra-
cardiac total anomalies had posterior 
approach whereby the common pulmonary 
venous chamber was widely (more than 4 cm) 
anastomozed to the left atrium to prevent 
obstruction. All patients with intra-cardiac 
anomalies underwent coronary sinus cut-back 
technique with glutaraldehyde pericardial 
patch closure of ASD while re-routing 
pulmonary venous blood into left atrium 
except one who underwent Van Praagh 
technique. 
All patients were started on cardiac support 
infusions; Milrinone (5-10µg/kg/min) and 
Dobutamine (2-20µg/kg/min) intra-
operatively and transferred to Cardiothoracic 
ICU for elective ventilation, cardiac support 
and monitoring.   
 
Results 
 
The study included a total of 65 patients 
whereby male accounted for 56.9% and 
female 43.1% (Table 1). Total anomalies 
were found in 39 patients accounting for 60% 
and 26 patients (40%) with partial anomalies 
(Tables 2 & 3). Mean age of presentation was 
21.6 months (variance = 832.71, SD=28.86) 
for TAPVC and 135.2 months (variance = 
27567.36, SD=166.03) for PAPVC (p = 
0.0031). Among patients with partial 
anomalies 17 (65.4%) had involvement of 
one pulmonary vein (right superior 
pulmonary vein), 8 (30.8%) had involvement 
of two veins (right superior and right inferior 
pulmonary veins) and only 1 patient (3.8%) 
had involvement of three pulmonary veins 
(two from right side and one from left side 
draining into innominate vein ). Majority of 
partial anomalies were associated with sinus 
venosus ASD (84.6%) and only 7.7% were 
associated with posterior ASD and 7.7% 
ostium secundum ASD (Table 2). 
 
Among all patients with TAPVC 17 (43.6%) 
had supra-cardiac type, 14 (35.9%) had intra-
cardiac type, 2 (5.1%) had infra-cardiac type 
and 6 (15.4%) had a mixed type (Table 3). 
TAPVC was associated with ostium 
secundum ASD in 20 patients accounting for 
51.3%. Other rare anomalies associated with 
TAPVC included LSVC, PDA and VSD 
(Table 4). Pulmonary hypertension was found 
in 29 out of 39 (74.4%) patients with TAPVC  
compared to 3 out of 26 (11.5%) patients with 
PAPVC (X2 = 24.63, p=0.000001).There 
were 6 deaths from TAPVC group compared 
to none from PAPVC.  
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All deaths were associated with severe 
pulmonary hypertension and 5 out of 6 were 2 
months old. These deaths occurred within 48 
hours of surgery except one that occurred on 
the seventh day and these were due to 
multiple organ failure due to low cardiac 
output syndrome and severe pulmonary 
hypertension. No patient reported to have 
post-operative pulmonary vein obstruction.  
 
Table 1. Age / Sex Distribution. 
 
Age group 
(months) 
 Male 
(%)     
Female 
(%) 
Total 
(%) 
0-12 19 11 30 
(46.2) 
13-60   6 13 19 
(29.2) 
> 61 12   4 16 
(24.6) 
Total 37 
(56.9) 
28 
(43.1) 
65 
(100)  
 
Table 2. Type of ASD associated with PAPVC 
 
Type of ASD Number % 
Sinus venosus ASD 22 84.6 
Posterior ASD 2 7.7 
Ostium secundum ASD 2 7.7 
 Total 26 100 
 
Table 3. Type of TAPVC 
 
Type of TAPVC Number % 
Supracardiac 17 43.6 
Intracardiac 14 35.9 
Infracardiac 2 5.1 
Mixed 6 15.4 
 Total 39 100 
 
Table 4. Anomalies  associated  with TAPVC 
 
Type of Anomaly  No.  (%)         
ASD 20  (51.3) 
Left Superior Vena Cava 
(LSVC) 
  2   (5.2) 
Patent Dactus Arteriosus 
(PDA) 
  1   (2.6) 
PDA + ASD   1   (2.6) 
PDA + LSVC   1   (2.6) 
Ventricular Septal Defect 
(VSD) 
  1   (2.6) 
Total 26 (66.7) 
Thirteen patients (33.3%) had no associated 
anomalies. 
 
Discussion 
 
 Anomalous Pulmonary Venous Connection 
present early in life. Lamb RK et al12) studied 
on APVC and found that 87.5% of all patients 
were less than 1 year old at time of operation. 
Our study revealed that 46.2% of all patients 
were 1-year old or less and TAPVC 
presenting early in life than PAPVC (mean 
age, 21.6 versus 135.2 months respectively, p 
= 0.0031). Male prepondence has been found 
in many studies1,7,12,13 as well as in our study. 
 
TAPVC occurs most common than the 
PAPVC. Snellen HA et al (1) studied on the 
patterns of APVC and found that TAPVC 
was 10 times more common than PAPVC. 
PAPVC mainly involves right pulmonary 
vein(s) and commonly associated with sinus 
venosus ASD1,3. NM Ammash et al6 while 
studying on the diagnosis of the PAPVC 
found that 81.4 % of the patients involved 
right pulmonary veins, 16.3 % involved left 
side and 2.3% was bilateral. CHA Jost et al3 
when evaluating a long term post-operative 
outcome for 115 patients with sinus venosus 
ASD found that 97% were associated with 
APVC. Our study revealed that TAPVC 
accounts for 60% of all patients compared to 
40% for PAPVC and among all patients with 
PAPVC 96.2% involved the right pulmonary 
veins. Supra-cardiac and intra-cardiac types 
of TAPVC are the commonest both 
accounting for 69.5% to 89.7% 4,10,12,13 which 
is comparable with our findings of 79.5%. 
Infra-cardiac and mixed types accounts for 
10.0% to 31.3% and 20.5% in our study. 
 
Definitive diagnosis for APVC is mainly 
made by Trans-Thoracic Echocardiography 
(TTE) and Trans-Esophageal 
Echocardiography (TEE) is considered for 
sinus venosus ASD or unexplained dilated 
right side of the heart by TTE6,7,8. 
 
PAPVC carries a low morbidity and mortality 
of less than 0.9% compared to TAPVC which 
carries a mortality of 7 to 31%4,5,10,11,12,13,14, 15. 
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TAPVC commonly is associated with ASD13 
and when associated with a complex intra-
cardiac anomaly the mortality increases to 
52%16.The commonest anomaly associated 
with TAPVC in our study is ASD accounting 
for 51.3%. Overall mortality rate from our 
study was 9.2%; all deaths from TAPVC 
group making a mortality of 15.4% for 
TAPVC group. Pulmonary hypertension 
occured significantly in patients with TAPVC 
compared to PAPVC (X2 = 24.63, 
p=0.000001) and subsequently prolonged 
duration of mechanical ventilation and ICU 
stay.  
 
Mortality in our study was attributed to 
pulmonary hypertension and low cardiac 
output syndrome. Choudhary et al 4 found 
that the predictors for early death in TAPVC 
included young age at operation, need for 
emergency surgery, malnutrition, pulmonary 
vein obstruction, pulmonary hypertension and 
low cardiac output syndrome.  
 
There was no patient who developed 
pulmonary vein obstruction or cardiac 
arrhythmias in our study. Prevalence of 
pulmonary vein obstruction has been reported 
in other studies ranging from 6% to 14% 
occurring between 2 to 12 weeks or longer 
following surgery for TAPVC12,13,14,15. 
Pulmonary vein obstruction carries a high 
morbidity and mortality of more than 27% for 
re-operation15. Cardiac arrhythmias occurs 
very late following surgery for TAPVC  and 
therefore a long term follow-up for these 
patients is recommended even when 
asymptomatic11,17. 
 
Conclusion 
TAPVC commonly present early in life and is 
associated with ASD and pulmonary 
hypertension. It carries a high morbidity and 
mortality. Accurate diagnosis and early 
surgical correction improves the surgical 
outcome. 
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